nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0435	0.0753	CbGbCtD
Bepridil—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0434	0.0751	CbGbCtD
Bepridil—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0409	0.0708	CbGbCtD
Bepridil—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0409	0.0708	CbGbCtD
Bepridil—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0393	0.0679	CbGbCtD
Bepridil—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.037	0.064	CbGbCtD
Bepridil—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.037	0.064	CbGbCtD
Bepridil—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0339	0.0587	CbGbCtD
Bepridil—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0329	0.0569	CbGbCtD
Bepridil—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0319	0.0553	CbGbCtD
Bepridil—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.031	0.0536	CbGbCtD
Bepridil—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0298	0.0515	CbGbCtD
Bepridil—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0298	0.0515	CbGbCtD
Bepridil—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0285	0.0494	CbGbCtD
Bepridil—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.028	0.0485	CbGbCtD
Bepridil—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.028	0.0485	CbGbCtD
Bepridil—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0221	0.0382	CbGbCtD
Bepridil—CACNA1A—nerve—acquired immunodeficiency syndrome	0.00814	0.0652	CbGeAlD
Bepridil—CALM2—semen—acquired immunodeficiency syndrome	0.00484	0.0387	CbGeAlD
Bepridil—CALM1—semen—acquired immunodeficiency syndrome	0.00481	0.0386	CbGeAlD
Bepridil—CALM2—nerve—acquired immunodeficiency syndrome	0.00233	0.0187	CbGeAlD
Bepridil—CALM1—nerve—acquired immunodeficiency syndrome	0.00232	0.0186	CbGeAlD
Bepridil—CALM2—endothelium—acquired immunodeficiency syndrome	0.00198	0.0159	CbGeAlD
Bepridil—CALM1—endothelium—acquired immunodeficiency syndrome	0.00197	0.0158	CbGeAlD
Bepridil—PDE1B—blood—acquired immunodeficiency syndrome	0.00197	0.0158	CbGeAlD
Bepridil—TNNC1—blood—acquired immunodeficiency syndrome	0.00189	0.0151	CbGeAlD
Bepridil—CACNA1A—nervous system—acquired immunodeficiency syndrome	0.00183	0.0147	CbGeAlD
Bepridil—CACNA1A—central nervous system—acquired immunodeficiency syndrome	0.00176	0.0141	CbGeAlD
Bepridil—CALM2—blood plasma—acquired immunodeficiency syndrome	0.00176	0.0141	CbGeAlD
Bepridil—CALM1—blood plasma—acquired immunodeficiency syndrome	0.00175	0.014	CbGeAlD
Bepridil—TNNC1—lung—acquired immunodeficiency syndrome	0.00165	0.0133	CbGeAlD
Bepridil—KCNQ1—digestive system—acquired immunodeficiency syndrome	0.00161	0.0129	CbGeAlD
Bepridil—PDE1B—nervous system—acquired immunodeficiency syndrome	0.0016	0.0128	CbGeAlD
Bepridil—PDE1A—spinal cord—acquired immunodeficiency syndrome	0.00159	0.0127	CbGeAlD
Bepridil—PDE1B—central nervous system—acquired immunodeficiency syndrome	0.00154	0.0123	CbGeAlD
Bepridil—KCNQ1—blood—acquired immunodeficiency syndrome	0.00153	0.0123	CbGeAlD
Bepridil—CACNA2D2—spinal cord—acquired immunodeficiency syndrome	0.00153	0.0123	CbGeAlD
Bepridil—KCNQ1—bone marrow—acquired immunodeficiency syndrome	0.00148	0.0119	CbGeAlD
Bepridil—CACNA2D2—vagina—acquired immunodeficiency syndrome	0.00147	0.0118	CbGeAlD
Bepridil—PDE1A—lung—acquired immunodeficiency syndrome	0.00145	0.0116	CbGeAlD
Bepridil—CACNA1A—brain—acquired immunodeficiency syndrome	0.0014	0.0112	CbGeAlD
Bepridil—CACNA2D2—lung—acquired immunodeficiency syndrome	0.00139	0.0112	CbGeAlD
Bepridil—KCNQ1—lung—acquired immunodeficiency syndrome	0.00134	0.0108	CbGeAlD
Bepridil—PDE1A—nervous system—acquired immunodeficiency syndrome	0.00134	0.0107	CbGeAlD
Bepridil—PDE1A—central nervous system—acquired immunodeficiency syndrome	0.00129	0.0103	CbGeAlD
Bepridil—CACNA2D2—nervous system—acquired immunodeficiency syndrome	0.00129	0.0103	CbGeAlD
Bepridil—CACNA2D2—central nervous system—acquired immunodeficiency syndrome	0.00124	0.00994	CbGeAlD
Bepridil—CALM3—retina—acquired immunodeficiency syndrome	0.00123	0.00984	CbGeAlD
Bepridil—PDE1B—brain—acquired immunodeficiency syndrome	0.00122	0.00978	CbGeAlD
Bepridil—PDE1B—lymph node—acquired immunodeficiency syndrome	0.00118	0.00945	CbGeAlD
Bepridil—TNNC1—lymph node—acquired immunodeficiency syndrome	0.00113	0.00906	CbGeAlD
Bepridil—ATP1A1—retina—acquired immunodeficiency syndrome	0.0011	0.00878	CbGeAlD
Bepridil—CACNA1H—nervous system—acquired immunodeficiency syndrome	0.00105	0.00837	CbGeAlD
Bepridil—CACNA1C—digestive system—acquired immunodeficiency syndrome	0.00103	0.00825	CbGeAlD
Bepridil—PDE1A—brain—acquired immunodeficiency syndrome	0.00102	0.0082	CbGeAlD
Bepridil—PDE1A—lymph node—acquired immunodeficiency syndrome	0.000989	0.00792	CbGeAlD
Bepridil—CACNA2D2—brain—acquired immunodeficiency syndrome	0.000985	0.00789	CbGeAlD
Bepridil—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000973	0.0078	CbGeAlD
Bepridil—CALM2—retina—acquired immunodeficiency syndrome	0.000965	0.00773	CbGeAlD
Bepridil—ATP1A1—skin of body—acquired immunodeficiency syndrome	0.000962	0.0077	CbGeAlD
Bepridil—CALM1—retina—acquired immunodeficiency syndrome	0.00096	0.00769	CbGeAlD
Bepridil—CACNA2D2—lymph node—acquired immunodeficiency syndrome	0.000952	0.00763	CbGeAlD
Bepridil—KCNQ1—brain—acquired immunodeficiency syndrome	0.000952	0.00762	CbGeAlD
Bepridil—CACNA1D—lung—acquired immunodeficiency syndrome	0.000932	0.00746	CbGeAlD
Bepridil—KCNQ1—lymph node—acquired immunodeficiency syndrome	0.00092	0.00737	CbGeAlD
Bepridil—CACNA1C—vagina—acquired immunodeficiency syndrome	0.00091	0.00729	CbGeAlD
Bepridil—CACNA1D—nervous system—acquired immunodeficiency syndrome	0.000863	0.00691	CbGeAlD
Bepridil—CACNA1C—lung—acquired immunodeficiency syndrome	0.00086	0.00689	CbGeAlD
Bepridil—CALM2—skin of body—acquired immunodeficiency syndrome	0.000847	0.00678	CbGeAlD
Bepridil—CALM1—skin of body—acquired immunodeficiency syndrome	0.000843	0.00675	CbGeAlD
Bepridil—CACNA1D—central nervous system—acquired immunodeficiency syndrome	0.000831	0.00666	CbGeAlD
Bepridil—CALM3—blood—acquired immunodeficiency syndrome	0.000822	0.00658	CbGeAlD
Bepridil—CACNA1H—brain—acquired immunodeficiency syndrome	0.000799	0.0064	CbGeAlD
Bepridil—CACNA1C—nervous system—acquired immunodeficiency syndrome	0.000797	0.00638	CbGeAlD
Bepridil—CALM3—bone marrow—acquired immunodeficiency syndrome	0.000795	0.00637	CbGeAlD
Bepridil—CALM3—spinal cord—acquired immunodeficiency syndrome	0.000792	0.00634	CbGeAlD
Bepridil—ATP1A1—lymphoid tissue—acquired immunodeficiency syndrome	0.000779	0.00624	CbGeAlD
Bepridil—CACNA1H—lymph node—acquired immunodeficiency syndrome	0.000772	0.00619	CbGeAlD
Bepridil—ATP1A1—digestive system—acquired immunodeficiency syndrome	0.000769	0.00616	CbGeAlD
Bepridil—CACNA1C—central nervous system—acquired immunodeficiency syndrome	0.000767	0.00614	CbGeAlD
Bepridil—CALM3—vagina—acquired immunodeficiency syndrome	0.000762	0.0061	CbGeAlD
Bepridil—ATP1A1—blood—acquired immunodeficiency syndrome	0.000733	0.00587	CbGeAlD
Bepridil—CALM3—lung—acquired immunodeficiency syndrome	0.000721	0.00577	CbGeAlD
Bepridil—ATP1A1—bone marrow—acquired immunodeficiency syndrome	0.000709	0.00568	CbGeAlD
Bepridil—ATP1A1—spinal cord—acquired immunodeficiency syndrome	0.000706	0.00566	CbGeAlD
Bepridil—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.0007	0.00561	CbGeAlD
Bepridil—CALM2—lymphoid tissue—acquired immunodeficiency syndrome	0.000686	0.00549	CbGeAlD
Bepridil—CALM1—lymphoid tissue—acquired immunodeficiency syndrome	0.000683	0.00547	CbGeAlD
Bepridil—ATP1A1—vagina—acquired immunodeficiency syndrome	0.000679	0.00544	CbGeAlD
Bepridil—CALM2—digestive system—acquired immunodeficiency syndrome	0.000678	0.00543	CbGeAlD
Bepridil—CALM1—digestive system—acquired immunodeficiency syndrome	0.000674	0.0054	CbGeAlD
Bepridil—CACNA1D—brain—acquired immunodeficiency syndrome	0.00066	0.00528	CbGeAlD
Bepridil—CALM2—blood—acquired immunodeficiency syndrome	0.000646	0.00517	CbGeAlD
Bepridil—ATP1A1—lung—acquired immunodeficiency syndrome	0.000643	0.00515	CbGeAlD
Bepridil—CALM1—blood—acquired immunodeficiency syndrome	0.000643	0.00515	CbGeAlD
Bepridil—CACNA1D—lymph node—acquired immunodeficiency syndrome	0.000637	0.00511	CbGeAlD
Bepridil—CALM2—bone marrow—acquired immunodeficiency syndrome	0.000625	0.005	CbGeAlD
Bepridil—CALM2—spinal cord—acquired immunodeficiency syndrome	0.000622	0.00498	CbGeAlD
Bepridil—CALM1—bone marrow—acquired immunodeficiency syndrome	0.000622	0.00498	CbGeAlD
Bepridil—CALM1—spinal cord—acquired immunodeficiency syndrome	0.000619	0.00496	CbGeAlD
Bepridil—CACNA1C—brain—acquired immunodeficiency syndrome	0.000609	0.00488	CbGeAlD
Bepridil—CALM2—vagina—acquired immunodeficiency syndrome	0.000598	0.00479	CbGeAlD
Bepridil—CALM1—vagina—acquired immunodeficiency syndrome	0.000596	0.00477	CbGeAlD
Bepridil—ATP1A1—nervous system—acquired immunodeficiency syndrome	0.000595	0.00477	CbGeAlD
Bepridil—CACNA1C—lymph node—acquired immunodeficiency syndrome	0.000588	0.00471	CbGeAlD
Bepridil—KCNH2—blood—acquired immunodeficiency syndrome	0.000585	0.00468	CbGeAlD
Bepridil—ATP1A1—central nervous system—acquired immunodeficiency syndrome	0.000573	0.00459	CbGeAlD
Bepridil—CALM2—lung—acquired immunodeficiency syndrome	0.000566	0.00453	CbGeAlD
Bepridil—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.000566	0.00453	CbGeAlD
Bepridil—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.000563	0.00451	CbGeAlD
Bepridil—CALM1—lung—acquired immunodeficiency syndrome	0.000563	0.00451	CbGeAlD
Bepridil—KCNH2—vagina—acquired immunodeficiency syndrome	0.000542	0.00434	CbGeAlD
Bepridil—CALM2—nervous system—acquired immunodeficiency syndrome	0.000524	0.0042	CbGeAlD
Bepridil—CALM1—nervous system—acquired immunodeficiency syndrome	0.000522	0.00418	CbGeAlD
Bepridil—CALM3—brain—acquired immunodeficiency syndrome	0.00051	0.00409	CbGeAlD
Bepridil—CALM2—central nervous system—acquired immunodeficiency syndrome	0.000505	0.00404	CbGeAlD
Bepridil—CALM1—central nervous system—acquired immunodeficiency syndrome	0.000502	0.00402	CbGeAlD
Bepridil—CALM3—lymph node—acquired immunodeficiency syndrome	0.000493	0.00395	CbGeAlD
Bepridil—KCNH2—nervous system—acquired immunodeficiency syndrome	0.000475	0.0038	CbGeAlD
Bepridil—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000459	0.00183	CcSEcCtD
Bepridil—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000458	0.00183	CcSEcCtD
Bepridil—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000458	0.00183	CcSEcCtD
Bepridil—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000457	0.00183	CcSEcCtD
Bepridil—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.000457	0.00366	CbGeAlD
Bepridil—ATP1A1—brain—acquired immunodeficiency syndrome	0.000455	0.00364	CbGeAlD
Bepridil—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000454	0.00181	CcSEcCtD
Bepridil—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000453	0.00181	CcSEcCtD
Bepridil—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000453	0.00181	CcSEcCtD
Bepridil—Shock—Indinavir—acquired immunodeficiency syndrome	0.000453	0.00181	CcSEcCtD
Bepridil—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000452	0.00181	CcSEcCtD
Bepridil—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000451	0.00181	CcSEcCtD
Bepridil—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000451	0.00181	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000451	0.0018	CcSEcCtD
Bepridil—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000451	0.0018	CcSEcCtD
Bepridil—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00045	0.0018	CcSEcCtD
Bepridil—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00045	0.0018	CcSEcCtD
Bepridil—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00045	0.0018	CcSEcCtD
Bepridil—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000449	0.00179	CcSEcCtD
Bepridil—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000448	0.00179	CcSEcCtD
Bepridil—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000447	0.00179	CcSEcCtD
Bepridil—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000447	0.00179	CcSEcCtD
Bepridil—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000445	0.00178	CcSEcCtD
Bepridil—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000445	0.00178	CcSEcCtD
Bepridil—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000444	0.00178	CcSEcCtD
Bepridil—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000444	0.00178	CcSEcCtD
Bepridil—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000444	0.00177	CcSEcCtD
Bepridil—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000443	0.00177	CcSEcCtD
Bepridil—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000443	0.00177	CcSEcCtD
Bepridil—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000442	0.00177	CcSEcCtD
Bepridil—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000441	0.00176	CcSEcCtD
Bepridil—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00044	0.00176	CcSEcCtD
Bepridil—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00044	0.00176	CcSEcCtD
Bepridil—ATP1A1—lymph node—acquired immunodeficiency syndrome	0.000439	0.00352	CbGeAlD
Bepridil—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000439	0.00175	CcSEcCtD
Bepridil—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000436	0.00174	CcSEcCtD
Bepridil—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000434	0.00174	CcSEcCtD
Bepridil—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000432	0.00173	CcSEcCtD
Bepridil—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00043	0.00172	CcSEcCtD
Bepridil—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000428	0.00171	CcSEcCtD
Bepridil—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000427	0.00171	CcSEcCtD
Bepridil—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000427	0.00171	CcSEcCtD
Bepridil—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000426	0.00171	CcSEcCtD
Bepridil—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000425	0.0017	CcSEcCtD
Bepridil—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000425	0.0017	CcSEcCtD
Bepridil—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000424	0.0017	CcSEcCtD
Bepridil—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000423	0.00169	CcSEcCtD
Bepridil—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000423	0.00169	CcSEcCtD
Bepridil—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000423	0.00169	CcSEcCtD
Bepridil—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000423	0.00169	CcSEcCtD
Bepridil—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000423	0.00169	CcSEcCtD
Bepridil—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00042	0.00168	CcSEcCtD
Bepridil—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.00168	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000419	0.00168	CcSEcCtD
Bepridil—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000417	0.00167	CcSEcCtD
Bepridil—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000416	0.00166	CcSEcCtD
Bepridil—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000416	0.00166	CcSEcCtD
Bepridil—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000414	0.00166	CcSEcCtD
Bepridil—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000414	0.00166	CcSEcCtD
Bepridil—Rash—Didanosine—acquired immunodeficiency syndrome	0.000413	0.00165	CcSEcCtD
Bepridil—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000413	0.00165	CcSEcCtD
Bepridil—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000413	0.00165	CcSEcCtD
Bepridil—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000411	0.00164	CcSEcCtD
Bepridil—Headache—Didanosine—acquired immunodeficiency syndrome	0.000411	0.00164	CcSEcCtD
Bepridil—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00041	0.00164	CcSEcCtD
Bepridil—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00041	0.00164	CcSEcCtD
Bepridil—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000409	0.00164	CcSEcCtD
Bepridil—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000409	0.00164	CcSEcCtD
Bepridil—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000408	0.00163	CcSEcCtD
Bepridil—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000408	0.00163	CcSEcCtD
Bepridil—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000407	0.00163	CcSEcCtD
Bepridil—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000407	0.00163	CcSEcCtD
Bepridil—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000405	0.00162	CcSEcCtD
Bepridil—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000405	0.00162	CcSEcCtD
Bepridil—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000405	0.00162	CcSEcCtD
Bepridil—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000403	0.00161	CcSEcCtD
Bepridil—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000402	0.00161	CcSEcCtD
Bepridil—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000402	0.00161	CcSEcCtD
Bepridil—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000401	0.0016	CcSEcCtD
Bepridil—CALM2—brain—acquired immunodeficiency syndrome	0.000401	0.00321	CbGeAlD
Bepridil—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.0004	0.0016	CcSEcCtD
Bepridil—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.0004	0.0016	CcSEcCtD
Bepridil—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000399	0.00159	CcSEcCtD
Bepridil—CALM1—brain—acquired immunodeficiency syndrome	0.000399	0.00319	CbGeAlD
Bepridil—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000397	0.00159	CcSEcCtD
Bepridil—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000397	0.00159	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000396	0.00158	CcSEcCtD
Bepridil—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000396	0.00158	CcSEcCtD
Bepridil—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000393	0.00157	CcSEcCtD
Bepridil—Pain—Indinavir—acquired immunodeficiency syndrome	0.000393	0.00157	CcSEcCtD
Bepridil—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000393	0.00157	CcSEcCtD
Bepridil—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000392	0.00157	CcSEcCtD
Bepridil—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000392	0.00157	CcSEcCtD
Bepridil—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000391	0.00156	CcSEcCtD
Bepridil—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000391	0.00156	CcSEcCtD
Bepridil—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000391	0.00156	CcSEcCtD
Bepridil—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00039	0.00156	CcSEcCtD
Bepridil—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000389	0.00156	CcSEcCtD
Bepridil—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000389	0.00156	CcSEcCtD
Bepridil—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000389	0.00156	CcSEcCtD
Bepridil—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000388	0.00155	CcSEcCtD
Bepridil—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000388	0.00155	CcSEcCtD
Bepridil—CALM2—lymph node—acquired immunodeficiency syndrome	0.000387	0.0031	CbGeAlD
Bepridil—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000386	0.00155	CcSEcCtD
Bepridil—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000386	0.00154	CcSEcCtD
Bepridil—CALM1—lymph node—acquired immunodeficiency syndrome	0.000385	0.00309	CbGeAlD
Bepridil—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000385	0.00154	CcSEcCtD
Bepridil—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000385	0.00154	CcSEcCtD
Bepridil—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000384	0.00153	CcSEcCtD
Bepridil—ABCB1—retina—acquired immunodeficiency syndrome	0.000383	0.00307	CbGeAlD
Bepridil—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000383	0.00153	CcSEcCtD
Bepridil—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00038	0.00152	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000379	0.00152	CcSEcCtD
Bepridil—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000378	0.00151	CcSEcCtD
Bepridil—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000378	0.00151	CcSEcCtD
Bepridil—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000378	0.00151	CcSEcCtD
Bepridil—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000378	0.00151	CcSEcCtD
Bepridil—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000378	0.00151	CcSEcCtD
Bepridil—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000376	0.00151	CcSEcCtD
Bepridil—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000376	0.0015	CcSEcCtD
Bepridil—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000376	0.0015	CcSEcCtD
Bepridil—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000375	0.0015	CcSEcCtD
Bepridil—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000374	0.003	CbGeAlD
Bepridil—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000374	0.00149	CcSEcCtD
Bepridil—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000372	0.00149	CcSEcCtD
Bepridil—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000372	0.00149	CcSEcCtD
Bepridil—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000372	0.00149	CcSEcCtD
Bepridil—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000372	0.00149	CcSEcCtD
Bepridil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000371	0.00149	CcSEcCtD
Bepridil—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000371	0.00148	CcSEcCtD
Bepridil—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000371	0.00148	CcSEcCtD
Bepridil—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00037	0.00148	CcSEcCtD
Bepridil—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00037	0.00148	CcSEcCtD
Bepridil—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000369	0.00148	CcSEcCtD
Bepridil—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000368	0.00147	CcSEcCtD
Bepridil—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000367	0.00147	CcSEcCtD
Bepridil—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000367	0.00147	CcSEcCtD
Bepridil—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000366	0.00146	CcSEcCtD
Bepridil—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000364	0.00146	CcSEcCtD
Bepridil—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000364	0.00145	CcSEcCtD
Bepridil—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000364	0.00145	CcSEcCtD
Bepridil—KCNH2—brain—acquired immunodeficiency syndrome	0.000363	0.00291	CbGeAlD
Bepridil—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000362	0.00145	CcSEcCtD
Bepridil—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00036	0.00144	CcSEcCtD
Bepridil—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00036	0.00144	CcSEcCtD
Bepridil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00036	0.00144	CcSEcCtD
Bepridil—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000359	0.00144	CcSEcCtD
Bepridil—Rash—Stavudine—acquired immunodeficiency syndrome	0.000359	0.00144	CcSEcCtD
Bepridil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000359	0.00143	CcSEcCtD
Bepridil—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000358	0.00143	CcSEcCtD
Bepridil—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000358	0.00143	CcSEcCtD
Bepridil—Headache—Stavudine—acquired immunodeficiency syndrome	0.000357	0.00143	CcSEcCtD
Bepridil—CYP2D6—blood—acquired immunodeficiency syndrome	0.000357	0.00286	CbGeAlD
Bepridil—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00142	CcSEcCtD
Bepridil—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00142	CcSEcCtD
Bepridil—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000356	0.00142	CcSEcCtD
Bepridil—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000355	0.00142	CcSEcCtD
Bepridil—Rash—Abacavir—acquired immunodeficiency syndrome	0.000354	0.00141	CcSEcCtD
Bepridil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000353	0.00141	CcSEcCtD
Bepridil—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000353	0.00141	CcSEcCtD
Bepridil—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000353	0.00141	CcSEcCtD
Bepridil—Headache—Abacavir—acquired immunodeficiency syndrome	0.000351	0.00141	CcSEcCtD
Bepridil—KCNH2—lymph node—acquired immunodeficiency syndrome	0.000351	0.00281	CbGeAlD
Bepridil—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00035	0.0014	CcSEcCtD
Bepridil—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00035	0.0014	CcSEcCtD
Bepridil—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000348	0.00139	CcSEcCtD
Bepridil—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000347	0.00139	CcSEcCtD
Bepridil—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000345	0.00138	CcSEcCtD
Bepridil—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000344	0.00137	CcSEcCtD
Bepridil—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000344	0.00137	CcSEcCtD
Bepridil—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000343	0.00137	CcSEcCtD
Bepridil—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000342	0.00137	CcSEcCtD
Bepridil—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.00137	CcSEcCtD
Bepridil—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.00136	CcSEcCtD
Bepridil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000339	0.00136	CcSEcCtD
Bepridil—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.00135	CcSEcCtD
Bepridil—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000339	0.00135	CcSEcCtD
Bepridil—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000338	0.00135	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.00135	CcSEcCtD
Bepridil—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000337	0.00135	CcSEcCtD
Bepridil—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000335	0.00134	CcSEcCtD
Bepridil—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000334	0.00134	CcSEcCtD
Bepridil—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000333	0.00133	CcSEcCtD
Bepridil—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000332	0.00133	CcSEcCtD
Bepridil—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000332	0.00133	CcSEcCtD
Bepridil—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00033	0.00132	CcSEcCtD
Bepridil—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00033	0.00132	CcSEcCtD
Bepridil—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000329	0.00132	CcSEcCtD
Bepridil—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000329	0.00132	CcSEcCtD
Bepridil—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000329	0.00132	CcSEcCtD
Bepridil—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000329	0.00132	CcSEcCtD
Bepridil—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000329	0.00132	CcSEcCtD
Bepridil—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000327	0.00131	CcSEcCtD
Bepridil—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.0013	CcSEcCtD
Bepridil—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000322	0.00129	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.00129	CcSEcCtD
Bepridil—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00032	0.00128	CcSEcCtD
Bepridil—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000319	0.00128	CcSEcCtD
Bepridil—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000317	0.00127	CcSEcCtD
Bepridil—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000317	0.00127	CcSEcCtD
Bepridil—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000317	0.00127	CcSEcCtD
Bepridil—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000315	0.00126	CcSEcCtD
Bepridil—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000315	0.00126	CcSEcCtD
Bepridil—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000315	0.00126	CcSEcCtD
Bepridil—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000314	0.00126	CcSEcCtD
Bepridil—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000312	0.00125	CcSEcCtD
Bepridil—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000312	0.00125	CcSEcCtD
Bepridil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000312	0.00125	CcSEcCtD
Bepridil—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.00124	CcSEcCtD
Bepridil—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.00124	CcSEcCtD
Bepridil—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000307	0.00123	CcSEcCtD
Bepridil—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000305	0.00122	CcSEcCtD
Bepridil—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000304	0.00122	CcSEcCtD
Bepridil—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.00122	CcSEcCtD
Bepridil—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.00122	CcSEcCtD
Bepridil—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.00121	CcSEcCtD
Bepridil—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00121	CcSEcCtD
Bepridil—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00121	CcSEcCtD
Bepridil—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000298	0.00119	CcSEcCtD
Bepridil—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000297	0.00119	CcSEcCtD
Bepridil—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000294	0.00118	CcSEcCtD
Bepridil—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.00117	CcSEcCtD
Bepridil—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.00117	CcSEcCtD
Bepridil—Rash—Indinavir—acquired immunodeficiency syndrome	0.00029	0.00116	CcSEcCtD
Bepridil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00029	0.00116	CcSEcCtD
Bepridil—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000289	0.00232	CbGeAlD
Bepridil—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.00116	CcSEcCtD
Bepridil—Headache—Indinavir—acquired immunodeficiency syndrome	0.000288	0.00115	CcSEcCtD
Bepridil—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000287	0.00115	CcSEcCtD
Bepridil—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000285	0.00114	CcSEcCtD
Bepridil—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.00112	CcSEcCtD
Bepridil—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.00112	CcSEcCtD
Bepridil—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000279	0.00223	CbGeAlD
Bepridil—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000276	0.0011	CcSEcCtD
Bepridil—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000275	0.0011	CcSEcCtD
Bepridil—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.0011	CcSEcCtD
Bepridil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.0011	CcSEcCtD
Bepridil—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000273	0.00109	CcSEcCtD
Bepridil—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000273	0.00218	CbGeAlD
Bepridil—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.00109	CcSEcCtD
Bepridil—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000269	0.00216	CbGeAlD
Bepridil—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000266	0.00106	CcSEcCtD
Bepridil—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000263	0.00105	CcSEcCtD
Bepridil—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Bepridil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Bepridil—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.00104	CcSEcCtD
Bepridil—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.00103	CcSEcCtD
Bepridil—ABCB1—blood—acquired immunodeficiency syndrome	0.000257	0.00205	CbGeAlD
Bepridil—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.00102	CcSEcCtD
Bepridil—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.00101	CcSEcCtD
Bepridil—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000253	0.00101	CcSEcCtD
Bepridil—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000248	0.00199	CbGeAlD
Bepridil—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000247	0.00198	CbGeAlD
Bepridil—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.000988	CcSEcCtD
Bepridil—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.000979	CcSEcCtD
Bepridil—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00097	CcSEcCtD
Bepridil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.000969	CcSEcCtD
Bepridil—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.000967	CcSEcCtD
Bepridil—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.000964	CcSEcCtD
Bepridil—ABCB1—vagina—acquired immunodeficiency syndrome	0.000238	0.0019	CbGeAlD
Bepridil—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.000934	CcSEcCtD
Bepridil—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000934	CcSEcCtD
Bepridil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000933	CcSEcCtD
Bepridil—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000928	CcSEcCtD
Bepridil—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000914	CcSEcCtD
Bepridil—ABCB1—lung—acquired immunodeficiency syndrome	0.000225	0.0018	CbGeAlD
Bepridil—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.000891	CcSEcCtD
Bepridil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00089	CcSEcCtD
Bepridil—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.000885	CcSEcCtD
Bepridil—CYP2D6—brain—acquired immunodeficiency syndrome	0.000221	0.00177	CbGeAlD
Bepridil—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.00088	CcSEcCtD
Bepridil—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.000839	CcSEcCtD
Bepridil—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000208	0.00167	CbGeAlD
Bepridil—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.0002	0.00161	CbGeAlD
Bepridil—ABCB1—brain—acquired immunodeficiency syndrome	0.000159	0.00127	CbGeAlD
Bepridil—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000154	0.00123	CbGeAlD
Bepridil—PDE1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.84e-05	0.000817	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.84e-05	0.000817	CbGpPWpGaD
Bepridil—CALM2—Immune System—ACTG1—acquired immunodeficiency syndrome	3.76e-05	0.0008	CbGpPWpGaD
Bepridil—CALM1—Immune System—ACTG1—acquired immunodeficiency syndrome	3.76e-05	0.0008	CbGpPWpGaD
Bepridil—PDE1B—Disease—CCR5—acquired immunodeficiency syndrome	3.76e-05	0.0008	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	3.75e-05	0.000797	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	3.75e-05	0.000797	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	3.64e-05	0.000775	CbGpPWpGaD
Bepridil—CALM3—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	3.62e-05	0.000771	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	3.61e-05	0.000768	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—ALB—acquired immunodeficiency syndrome	3.54e-05	0.000753	CbGpPWpGaD
Bepridil—CALM2—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	3.51e-05	0.000746	CbGpPWpGaD
Bepridil—CALM1—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	3.51e-05	0.000746	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	3.49e-05	0.000743	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	3.49e-05	0.000743	CbGpPWpGaD
Bepridil—CALM3—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	3.45e-05	0.000734	CbGpPWpGaD
Bepridil—CALM3—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	3.42e-05	0.000728	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—TNF—acquired immunodeficiency syndrome	3.41e-05	0.000726	CbGpPWpGaD
Bepridil—CACNA1C—Axon guidance—IL6—acquired immunodeficiency syndrome	3.39e-05	0.000721	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—CSF2—acquired immunodeficiency syndrome	3.37e-05	0.000716	CbGpPWpGaD
Bepridil—CALM2—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	3.34e-05	0.00071	CbGpPWpGaD
Bepridil—CALM1—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	3.34e-05	0.00071	CbGpPWpGaD
Bepridil—CALM2—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	3.31e-05	0.000704	CbGpPWpGaD
Bepridil—CALM1—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	3.31e-05	0.000704	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.29e-05	0.000699	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—CSF2—acquired immunodeficiency syndrome	3.26e-05	0.000693	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—CSF2—acquired immunodeficiency syndrome	3.26e-05	0.000693	CbGpPWpGaD
Bepridil—CALM3—Immune System—MBL2—acquired immunodeficiency syndrome	3.2e-05	0.00068	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.2e-05	0.00068	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.15e-05	0.00067	CbGpPWpGaD
Bepridil—PDE1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.1e-05	0.00066	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	3.1e-05	0.000659	CbGpPWpGaD
Bepridil—CALM2—Immune System—MBL2—acquired immunodeficiency syndrome	3.09e-05	0.000658	CbGpPWpGaD
Bepridil—CALM1—Immune System—MBL2—acquired immunodeficiency syndrome	3.09e-05	0.000658	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.03e-05	0.000645	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—TNF—acquired immunodeficiency syndrome	3e-05	0.000638	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	2.94e-05	0.000626	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.93e-05	0.000624	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.93e-05	0.000624	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.92e-05	0.000622	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	2.92e-05	0.00062	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	2.91e-05	0.000619	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.9e-05	0.000617	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.9e-05	0.000617	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IFNG—acquired immunodeficiency syndrome	2.89e-05	0.000616	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.88e-05	0.000612	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.88e-05	0.000612	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	2.85e-05	0.000606	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	2.85e-05	0.000606	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.84e-05	0.000603	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	2.82e-05	0.0006	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	2.82e-05	0.0006	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.82e-05	0.000599	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	2.82e-05	0.000599	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	2.82e-05	0.000599	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.8e-05	0.000597	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.8e-05	0.000597	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.8e-05	0.000597	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.8e-05	0.000597	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	2.8e-05	0.000596	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CD4—acquired immunodeficiency syndrome	2.8e-05	0.000595	CbGpPWpGaD
Bepridil—CALM3—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	2.78e-05	0.000592	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.75e-05	0.000586	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.74e-05	0.000583	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	2.71e-05	0.000576	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	2.71e-05	0.000576	CbGpPWpGaD
Bepridil—CALM3—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	2.69e-05	0.000573	CbGpPWpGaD
Bepridil—CALM2—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	2.69e-05	0.000572	CbGpPWpGaD
Bepridil—CALM1—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	2.69e-05	0.000572	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.65e-05	0.000564	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.65e-05	0.000564	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IFNG—acquired immunodeficiency syndrome	2.65e-05	0.000563	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.63e-05	0.00056	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.62e-05	0.000558	CbGpPWpGaD
Bepridil—CALM3—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	2.61e-05	0.000556	CbGpPWpGaD
Bepridil—CALM1—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	2.61e-05	0.000555	CbGpPWpGaD
Bepridil—CALM2—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	2.61e-05	0.000555	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	2.6e-05	0.000553	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.6e-05	0.000552	CbGpPWpGaD
Bepridil—CALM3—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	2.59e-05	0.000551	CbGpPWpGaD
Bepridil—PDE1A—Disease—CD4—acquired immunodeficiency syndrome	2.58e-05	0.000549	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.58e-05	0.000549	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.58e-05	0.000549	CbGpPWpGaD
Bepridil—CALM3—DAP12 signaling—IL6—acquired immunodeficiency syndrome	2.58e-05	0.000548	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.57e-05	0.000548	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL2—acquired immunodeficiency syndrome	2.57e-05	0.000547	CbGpPWpGaD
Bepridil—PDE1B—Immune System—CD4—acquired immunodeficiency syndrome	2.56e-05	0.000544	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.54e-05	0.00054	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.54e-05	0.00054	CbGpPWpGaD
Bepridil—CALM2—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	2.53e-05	0.000538	CbGpPWpGaD
Bepridil—CALM1—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	2.53e-05	0.000538	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	2.52e-05	0.000535	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	2.52e-05	0.000535	CbGpPWpGaD
Bepridil—CALM3—Immune System—CCR2—acquired immunodeficiency syndrome	2.51e-05	0.000533	CbGpPWpGaD
Bepridil—CALM1—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	2.5e-05	0.000533	CbGpPWpGaD
Bepridil—CALM2—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	2.5e-05	0.000533	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.49e-05	0.000531	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.49e-05	0.000531	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.49e-05	0.000531	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.49e-05	0.000531	CbGpPWpGaD
Bepridil—CALM1—DAP12 signaling—IL6—acquired immunodeficiency syndrome	2.49e-05	0.00053	CbGpPWpGaD
Bepridil—CALM2—DAP12 signaling—IL6—acquired immunodeficiency syndrome	2.49e-05	0.00053	CbGpPWpGaD
Bepridil—CALM2—Immune System—CCR2—acquired immunodeficiency syndrome	2.42e-05	0.000516	CbGpPWpGaD
Bepridil—CALM1—Immune System—CCR2—acquired immunodeficiency syndrome	2.42e-05	0.000516	CbGpPWpGaD
Bepridil—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.42e-05	0.000516	CbGpPWpGaD
Bepridil—CALM3—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.42e-05	0.000516	CbGpPWpGaD
Bepridil—CALM3—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.42e-05	0.000516	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.42e-05	0.000515	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.4e-05	0.000511	CbGpPWpGaD
Bepridil—CALM3—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.38e-05	0.000506	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.37e-05	0.000505	CbGpPWpGaD
Bepridil—CALM3—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.37e-05	0.000504	CbGpPWpGaD
Bepridil—PDE1B—Disease—CD4—acquired immunodeficiency syndrome	2.36e-05	0.000502	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL2—acquired immunodeficiency syndrome	2.35e-05	0.000501	CbGpPWpGaD
Bepridil—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.34e-05	0.000499	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.34e-05	0.000499	CbGpPWpGaD
Bepridil—CALM1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.34e-05	0.000499	CbGpPWpGaD
Bepridil—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.34e-05	0.000499	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.34e-05	0.000499	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.34e-05	0.000499	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.32e-05	0.000494	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.32e-05	0.000494	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.3e-05	0.00049	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.3e-05	0.00049	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—ALB—acquired immunodeficiency syndrome	2.3e-05	0.000489	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.29e-05	0.000488	CbGpPWpGaD
Bepridil—CALM2—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.29e-05	0.000488	CbGpPWpGaD
Bepridil—CALM3—Immune System—IFNA1—acquired immunodeficiency syndrome	2.26e-05	0.00048	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—ALB—acquired immunodeficiency syndrome	2.19e-05	0.000467	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD79A—acquired immunodeficiency syndrome	2.19e-05	0.000466	CbGpPWpGaD
Bepridil—CALM2—Immune System—IFNA1—acquired immunodeficiency syndrome	2.18e-05	0.000464	CbGpPWpGaD
Bepridil—CALM1—Immune System—IFNA1—acquired immunodeficiency syndrome	2.18e-05	0.000464	CbGpPWpGaD
Bepridil—CALM3—Disease—CXCR4—acquired immunodeficiency syndrome	2.17e-05	0.000463	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.15e-05	0.000457	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.14e-05	0.000456	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—ALB—acquired immunodeficiency syndrome	2.12e-05	0.000452	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—ALB—acquired immunodeficiency syndrome	2.12e-05	0.000452	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD79A—acquired immunodeficiency syndrome	2.12e-05	0.000451	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD79A—acquired immunodeficiency syndrome	2.12e-05	0.000451	CbGpPWpGaD
Bepridil—CALM2—Disease—CXCR4—acquired immunodeficiency syndrome	2.1e-05	0.000448	CbGpPWpGaD
Bepridil—CALM1—Disease—CXCR4—acquired immunodeficiency syndrome	2.1e-05	0.000448	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.08e-05	0.000442	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.08e-05	0.000442	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—ALB—acquired immunodeficiency syndrome	2.02e-05	0.000429	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.96e-05	0.000417	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.93e-05	0.000411	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.9e-05	0.000404	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.9e-05	0.000404	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.87e-05	0.000398	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.87e-05	0.000398	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.79e-05	0.000381	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD40LG—acquired immunodeficiency syndrome	1.79e-05	0.00038	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—IL2—acquired immunodeficiency syndrome	1.78e-05	0.000379	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.77e-05	0.000376	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD8A—acquired immunodeficiency syndrome	1.77e-05	0.000376	CbGpPWpGaD
Bepridil—CALM3—Immune System—CSF2—acquired immunodeficiency syndrome	1.77e-05	0.000376	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.74e-05	0.00037	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.73e-05	0.000369	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.73e-05	0.000369	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD40LG—acquired immunodeficiency syndrome	1.73e-05	0.000367	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD40LG—acquired immunodeficiency syndrome	1.73e-05	0.000367	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—IL2—acquired immunodeficiency syndrome	1.72e-05	0.000366	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—IL2—acquired immunodeficiency syndrome	1.72e-05	0.000366	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.71e-05	0.000364	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.71e-05	0.000364	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD8A—acquired immunodeficiency syndrome	1.71e-05	0.000363	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD8A—acquired immunodeficiency syndrome	1.71e-05	0.000363	CbGpPWpGaD
Bepridil—CALM2—Immune System—CSF2—acquired immunodeficiency syndrome	1.71e-05	0.000363	CbGpPWpGaD
Bepridil—CALM1—Immune System—CSF2—acquired immunodeficiency syndrome	1.71e-05	0.000363	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-B—acquired immunodeficiency syndrome	1.7e-05	0.000361	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.68e-05	0.000358	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.68e-05	0.000358	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.67e-05	0.000356	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.66e-05	0.000354	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.65e-05	0.000352	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.65e-05	0.000351	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-B—acquired immunodeficiency syndrome	1.64e-05	0.00035	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-B—acquired immunodeficiency syndrome	1.64e-05	0.00035	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.62e-05	0.000345	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.62e-05	0.000344	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.62e-05	0.000344	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.6e-05	0.00034	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.6e-05	0.00034	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.57e-05	0.000333	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.57e-05	0.000333	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.52e-05	0.000324	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.52e-05	0.000324	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.52e-05	0.000324	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.51e-05	0.000322	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL6—acquired immunodeficiency syndrome	1.51e-05	0.000322	CbGpPWpGaD
Bepridil—CALM3—Disease—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000317	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.47e-05	0.000313	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.47e-05	0.000313	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.47e-05	0.000313	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.47e-05	0.000313	CbGpPWpGaD
Bepridil—CALM2—Disease—CCR5—acquired immunodeficiency syndrome	1.44e-05	0.000307	CbGpPWpGaD
Bepridil—CALM1—Disease—CCR5—acquired immunodeficiency syndrome	1.44e-05	0.000307	CbGpPWpGaD
Bepridil—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.44e-05	0.000306	CbGpPWpGaD
Bepridil—PDE1A—Disease—IL6—acquired immunodeficiency syndrome	1.4e-05	0.000297	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL6—acquired immunodeficiency syndrome	1.38e-05	0.000294	CbGpPWpGaD
Bepridil—PDE1B—Disease—IL6—acquired immunodeficiency syndrome	1.28e-05	0.000272	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.16e-05	0.000247	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.14e-05	0.000243	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.12e-05	0.000238	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.12e-05	0.000238	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.1e-05	0.000235	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.1e-05	0.000235	CbGpPWpGaD
Bepridil—CALM3—Immune System—IFNG—acquired immunodeficiency syndrome	1.05e-05	0.000223	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.04e-05	0.000222	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.02e-05	0.000217	CbGpPWpGaD
Bepridil—CALM2—Immune System—IFNG—acquired immunodeficiency syndrome	1.02e-05	0.000216	CbGpPWpGaD
Bepridil—CALM1—Immune System—IFNG—acquired immunodeficiency syndrome	1.02e-05	0.000216	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD4—acquired immunodeficiency syndrome	1.01e-05	0.000216	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.01e-05	0.000215	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.01e-05	0.000215	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.88e-06	0.00021	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.88e-06	0.00021	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD4—acquired immunodeficiency syndrome	9.81e-06	0.000209	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD4—acquired immunodeficiency syndrome	9.81e-06	0.000209	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.78e-06	0.000208	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6—acquired immunodeficiency syndrome	9.41e-06	0.0002	CbGpPWpGaD
Bepridil—CALM3—Disease—CD4—acquired immunodeficiency syndrome	9.36e-06	0.000199	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL2—acquired immunodeficiency syndrome	9.33e-06	0.000198	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—acquired immunodeficiency syndrome	9.11e-06	0.000194	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—acquired immunodeficiency syndrome	9.11e-06	0.000194	CbGpPWpGaD
Bepridil—CALM1—Disease—CD4—acquired immunodeficiency syndrome	9.05e-06	0.000193	CbGpPWpGaD
Bepridil—CALM2—Disease—CD4—acquired immunodeficiency syndrome	9.05e-06	0.000193	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL2—acquired immunodeficiency syndrome	9.02e-06	0.000192	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL2—acquired immunodeficiency syndrome	9.02e-06	0.000192	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.94e-06	0.00019	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ALB—acquired immunodeficiency syndrome	8.89e-06	0.000189	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ALB—acquired immunodeficiency syndrome	8.6e-06	0.000183	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ALB—acquired immunodeficiency syndrome	8.6e-06	0.000183	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	6.74e-06	0.000143	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	6.35e-06	0.000135	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.03e-06	0.000128	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6e-06	0.000128	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.83e-06	0.000124	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.83e-06	0.000124	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.8e-06	0.000124	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.8e-06	0.000124	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—acquired immunodeficiency syndrome	5.48e-06	0.000117	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—acquired immunodeficiency syndrome	5.3e-06	0.000113	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—acquired immunodeficiency syndrome	5.3e-06	0.000113	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—acquired immunodeficiency syndrome	5.06e-06	0.000108	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—acquired immunodeficiency syndrome	4.9e-06	0.000104	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—acquired immunodeficiency syndrome	4.9e-06	0.000104	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.54e-06	7.54e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.43e-06	7.3e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.43e-06	7.3e-05	CbGpPWpGaD
